Urinary  ||| S:0 E:8 ||| NNP
pH  ||| S:8 E:11 ||| NNP
and  ||| S:11 E:15 ||| CC
stone  ||| S:15 E:21 ||| NN
formation  ||| S:21 E:31 ||| NN
The  ||| S:31 E:35 ||| DT
formation  ||| S:35 E:45 ||| NN
of  ||| S:45 E:48 ||| IN
various  ||| S:48 E:56 ||| JJ
types  ||| S:56 E:62 ||| NNS
of  ||| S:62 E:65 ||| IN
kidney  ||| S:65 E:72 ||| NN
stones  ||| S:72 E:79 ||| NNS
is  ||| S:79 E:82 ||| VBZ
strongly  ||| S:82 E:91 ||| RB
influenced  ||| S:91 E:102 ||| VBN
by  ||| S:102 E:105 ||| IN
urinary  ||| S:105 E:113 ||| JJ
pH ||| S:113 E:115 ||| NN
.  ||| S:115 E:117 ||| .
An  ||| S:117 E:120 ||| DT
alkaline  ||| S:120 E:129 ||| JJ
pH  ||| S:129 E:132 ||| NN
favors  ||| S:132 E:139 ||| VBZ
the  ||| S:139 E:143 ||| DT
crystallization  ||| S:143 E:159 ||| NN
of  ||| S:159 E:162 ||| IN
calcium-  ||| S:162 E:171 ||| JJ
and  ||| S:171 E:175 ||| CC
phosphate-containing  ||| S:175 E:196 ||| JJ
stones ||| S:196 E:202 ||| NNS
,  ||| S:202 E:204 ||| ,
whereas  ||| S:204 E:212 ||| NN
and  ||| S:212 E:216 ||| CC
acidic  ||| S:216 E:223 ||| FW
urine  ||| S:223 E:229 ||| FW
pH  ||| S:229 E:232 ||| FW
promotes  ||| S:232 E:241 ||| FW
uric  ||| S:241 E:246 ||| FW
acid  ||| S:246 E:251 ||| FW
or  ||| S:251 E:254 ||| CC
cystine  ||| S:254 E:262 ||| JJ
stones ||| S:262 E:268 ||| NNS
.  ||| S:268 E:270 ||| .
The  ||| S:270 E:274 ||| DT
activity  ||| S:274 E:283 ||| NN
of  ||| S:283 E:286 ||| IN
many  ||| S:286 E:291 ||| JJ
transport  ||| S:291 E:301 ||| NN
processes  ||| S:301 E:311 ||| VBZ
involved  ||| S:311 E:320 ||| VBN
in  ||| S:320 E:323 ||| IN
calcium ||| S:323 E:330 ||| NN
,  ||| S:330 E:332 ||| ,
citrate  ||| S:332 E:340 ||| NN
and  ||| S:340 E:344 ||| CC
phosphate  ||| S:344 E:354 ||| JJ
handling  ||| S:354 E:363 ||| NN
are  ||| S:363 E:367 ||| VBP
sensitive  ||| S:367 E:377 ||| JJ
to  ||| S:377 E:380 ||| TO
changes  ||| S:380 E:388 ||| NNS
in  ||| S:388 E:391 ||| IN
systemic  ||| S:391 E:400 ||| JJ
or  ||| S:400 E:403 ||| CC
local  ||| S:403 E:409 ||| JJ
pH  ||| S:409 E:412 ||| NN
as  ||| S:412 E:415 ||| IN
shown  ||| S:415 E:421 ||| VBN
for  ||| S:421 E:425 ||| IN
several  ||| S:425 E:433 ||| JJ
phosphate  ||| S:433 E:443 ||| JJ
transporters ||| S:443 E:455 ||| NN
,  ||| S:455 E:457 ||| ,
the  ||| S:457 E:461 ||| DT
citrate  ||| S:461 E:469 ||| JJ
transporter  ||| S:469 E:481 ||| NN
NaDC1  ||| S:481 E:487 ||| NN
and  ||| S:487 E:491 ||| CC
the  ||| S:491 E:495 ||| DT
TRPV5  ||| S:495 E:501 ||| JJ
calcium  ||| S:501 E:509 ||| NN
channel ||| S:509 E:516 ||| NN
.  ||| S:516 E:518 ||| .
Defects  ||| S:518 E:526 ||| NNS
in  ||| S:526 E:529 ||| IN
urinary  ||| S:529 E:537 ||| JJ
acidification  ||| S:537 E:551 ||| NNS
( ||| S:551 E:552 ||| -LRB-
excretion  ||| S:552 E:562 ||| NN
of  ||| S:562 E:565 ||| IN
inappropriately  ||| S:565 E:581 ||| JJ
alkaline  ||| S:581 E:590 ||| NN
or  ||| S:590 E:593 ||| CC
acidic  ||| S:593 E:600 ||| JJ
urines ||| S:600 E:606 ||| NN
,  ||| S:606 E:608 ||| ,
respectively ||| S:608 E:620 ||| RB
)  ||| S:620 E:622 ||| -RRB-
contribute  ||| S:622 E:633 ||| VBP
to  ||| S:633 E:636 ||| TO
kidney  ||| S:636 E:643 ||| NN
stone  ||| S:643 E:649 ||| NN
disease ||| S:649 E:656 ||| NN
.  ||| S:656 E:658 ||| .
The  ||| S:658 E:662 ||| DT
low  ||| S:662 E:666 ||| JJ
excretion  ||| S:666 E:676 ||| NN
of  ||| S:676 E:679 ||| IN
ammonium  ||| S:679 E:688 ||| NN
in  ||| S:688 E:691 ||| IN
patients  ||| S:691 E:700 ||| NNS
with  ||| S:700 E:705 ||| IN
metabolic  ||| S:705 E:715 ||| JJ
syndrome  ||| S:715 E:724 ||| NN
has  ||| S:724 E:728 ||| VBZ
been  ||| S:728 E:733 ||| VBN
linked  ||| S:733 E:740 ||| VBN
to  ||| S:740 E:743 ||| TO
more  ||| S:743 E:748 ||| RBR
acidic  ||| S:748 E:755 ||| JJ
urine  ||| S:755 E:761 ||| NN
and  ||| S:761 E:765 ||| CC
a  ||| S:765 E:767 ||| DT
higher  ||| S:767 E:774 ||| JJR
incidence  ||| S:774 E:784 ||| NN
of  ||| S:784 E:787 ||| IN
uric  ||| S:787 E:792 ||| JJ
acid  ||| S:792 E:797 ||| NN
stones ||| S:797 E:803 ||| NNS
.  ||| S:803 E:805 ||| .
In  ||| S:805 E:808 ||| IN
this  ||| S:808 E:813 ||| DT
state ||| S:813 E:818 ||| NN
,  ||| S:818 E:820 ||| ,
insulin  ||| S:820 E:828 ||| NN
resistance  ||| S:828 E:839 ||| NN
may  ||| S:839 E:843 ||| MD
reduce  ||| S:843 E:850 ||| VB
ammonium  ||| S:850 E:859 ||| JJ
excretion  ||| S:859 E:869 ||| NN
by  ||| S:869 E:872 ||| IN
the  ||| S:872 E:876 ||| DT
proximal  ||| S:876 E:885 ||| JJ
tubule ||| S:885 E:891 ||| NN
.  ||| S:891 E:893 ||| .
On  ||| S:893 E:896 ||| IN
the  ||| S:896 E:900 ||| DT
other  ||| S:900 E:906 ||| JJ
hand ||| S:906 E:910 ||| NN
,  ||| S:910 E:912 ||| ,
defensive  ||| S:912 E:922 ||| JJ
mechanisms  ||| S:922 E:933 ||| NNS
may  ||| S:933 E:937 ||| MD
protect  ||| S:937 E:945 ||| VB
from  ||| S:945 E:950 ||| IN
kidney  ||| S:950 E:957 ||| NN
stone  ||| S:957 E:963 ||| NN
formation  ||| S:963 E:973 ||| NN
in  ||| S:973 E:976 ||| IN
conditions  ||| S:976 E:987 ||| NNS
such  ||| S:987 E:992 ||| JJ
as  ||| S:992 E:995 ||| IN
hypercalciuria  ||| S:995 E:1010 ||| NN
where  ||| S:1010 E:1016 ||| WRB
high  ||| S:1016 E:1021 ||| JJ
luminal  ||| S:1021 E:1029 ||| FW
calcium  ||| S:1029 E:1037 ||| FW
concentrations  ||| S:1037 E:1052 ||| FW
stimulate  ||| S:1052 E:1062 ||| FW
urinary  ||| S:1062 E:1070 ||| FW
acidification  ||| S:1070 E:1084 ||| FW
and  ||| S:1084 E:1088 ||| CC
reduce  ||| S:1088 E:1095 ||| VB
urinary  ||| S:1095 E:1103 ||| JJ
concentration  ||| S:1103 E:1117 ||| NN
via  ||| S:1117 E:1121 ||| IN
a  ||| S:1121 E:1123 ||| DT
calcium-sensing  ||| S:1123 E:1139 ||| JJ
receptor ||| S:1139 E:1147 ||| NN
,  ||| S:1147 E:1149 ||| ,
resulting  ||| S:1149 E:1159 ||| VBG
in  ||| S:1159 E:1162 ||| IN
the  ||| S:1162 E:1166 ||| DT
excretion  ||| S:1166 E:1176 ||| NN
of  ||| S:1176 E:1179 ||| IN
acidic  ||| S:1179 E:1186 ||| NN
and  ||| S:1186 E:1190 ||| CC
diluted  ||| S:1190 E:1198 ||| JJ
urine ||| S:1198 E:1203 ||| NN
.  ||| S:1203 E:1205 ||| .
This  ||| S:1205 E:1210 ||| DT
review  ||| S:1210 E:1217 ||| NN
will  ||| S:1217 E:1222 ||| MD
discuss  ||| S:1222 E:1230 ||| VB
a  ||| S:1230 E:1232 ||| DT
few  ||| S:1232 E:1236 ||| JJ
aspects  ||| S:1236 E:1244 ||| NNS
that  ||| S:1244 E:1249 ||| WDT
relate  ||| S:1249 E:1256 ||| VBP
to  ||| S:1256 E:1259 ||| TO
the  ||| S:1259 E:1263 ||| DT
capacity  ||| S:1263 E:1272 ||| NN
of  ||| S:1272 E:1275 ||| IN
the  ||| S:1275 E:1279 ||| DT
kidney  ||| S:1279 E:1286 ||| NN
to  ||| S:1286 E:1289 ||| TO
regulate  ||| S:1289 E:1298 ||| VB
pH  ||| S:1298 E:1301 ||| JJ
and  ||| S:1301 E:1305 ||| CC
its  ||| S:1305 E:1309 ||| PRP$
impact  ||| S:1309 E:1316 ||| NN
on  ||| S:1316 E:1319 ||| IN
the  ||| S:1319 E:1323 ||| DT
excretion  ||| S:1323 E:1333 ||| NN
of  ||| S:1333 E:1336 ||| IN
solutes  ||| S:1336 E:1344 ||| NNS
that  ||| S:1344 E:1349 ||| WDT
participate  ||| S:1349 E:1361 ||| VBP
in  ||| S:1361 E:1364 ||| IN
the  ||| S:1364 E:1368 ||| DT
formation  ||| S:1368 E:1378 ||| NN
or  ||| S:1378 E:1381 ||| CC
prevention  ||| S:1381 E:1392 ||| NN
of  ||| S:1392 E:1395 ||| IN
stones ||| S:1395 E:1401 ||| NNS
.  ||| S:1401 E:1403 ||| .
